Xinyu Zhou Selected Research

Pindolol (LB 46)

5/2015	Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
4/2015	Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinyu Zhou Research Topics

Disease

16	Neoplasms (Cancer) 07/2022 - 03/2015
8	Treatment-Resistant Depressive Disorder 01/2020 - 11/2014
7	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2016
7	Depressive Disorder (Melancholia) 01/2022 - 01/2015
5	Inflammation (Inflammations) 11/2022 - 01/2020
5	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 08/2016
5	Hypoxia (Hypoxemia) 07/2022 - 07/2014
5	Infections 11/2021 - 03/2014
4	Fibrosis (Cirrhosis) 01/2022 - 09/2017
4	Ischemia 01/2022 - 04/2016
4	Wounds and Injuries (Trauma) 11/2021 - 07/2014
3	Myocardial Infarction 01/2022 - 09/2017
3	Triple Negative Breast Neoplasms 01/2021 - 09/2018
3	Body Weight (Weight, Body) 01/2021 - 05/2016
2	Carcinogenesis 07/2022 - 08/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 12/2020
2	Malaria 02/2022 - 09/2020
2	Ischemic Stroke 01/2022 - 06/2021
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
2	Anhedonia 01/2022 - 05/2016
2	Acute Lung Injury 01/2022 - 01/2021
2	Stroke (Strokes) 01/2022 - 01/2018
2	Infarction (Infarctions) 01/2022 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 12/2021 - 09/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 09/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2018
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 09/2020
2	Corneal Injuries 01/2020 - 01/2019
2	Anxiety Disorders (Anxiety Disorder) 01/2018 - 10/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2022
1	Dysbiosis 10/2022
1	Obesity 08/2022
1	Glucose Intolerance 08/2022
1	Squamous Cell Carcinoma of Head and Neck 08/2022
1	Stomach Neoplasms (Stomach Cancer) 06/2022
1	Muscle Cramp (Cramp) 04/2022
1	Hyperlipidemias (Hyperlipidemia) 04/2022
1	Pancreatitis 04/2022
1	Urinary Incontinence 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Lung Injury 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Reperfusion Injury 12/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2021
1	Hypercholesterolemia 10/2021

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 11/2022 - 07/2014
12	Antidepressive Agents (Antidepressants)IBA 01/2022 - 11/2014
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 03/2014
4	Pharmaceutical PreparationsIBA 02/2022 - 09/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2015
4	Sucrose (Saccharose)IBA 01/2022 - 05/2016
3	LipidsIBA 10/2022 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2022
3	Peptides (Polypeptides)IBA 04/2022 - 09/2017
3	artemisinin (artemisinine)IBA 02/2022 - 09/2020
2	RNA (Ribonucleic Acid)IBA 07/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 07/2022 - 04/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2021
2	AntioxidantsIBA 01/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2019
2	artenimol (dihydroartemisinin)IBA 01/2021 - 09/2020
2	Glutamic Acid (Glutamate)FDA Link 08/2020 - 01/2019
2	InterferonsIBA 04/2020 - 01/2020
2	Oxygen (Dioxygen)IBA 01/2018 - 01/2017
2	Antipsychotic Agents (Antipsychotics)IBA 05/2015 - 11/2014
2	Pindolol (LB 46)FDA LinkGeneric 05/2015 - 04/2015
1	Amino Acids FDA Link 10/2022
1	Insulin (Novolin)FDA Link 08/2022
1	PowdersIBA 08/2022
1	MicroRNAs (MicroRNA)IBA 08/2022
1	CytokinesIBA 07/2022
1	Circulating Tumor DNAIBA 06/2022
1	Zonula Occludens-1 ProteinIBA 04/2022
1	OccludinIBA 04/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	Resistant StarchIBA 04/2022
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2022
1	lenvatinibIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	SynucleinsIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	Irritants (Vesicants)IBA 01/2022
1	UbiquitinIBA 01/2022
1	SugarsIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	EsterasesIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2022
1	NucleotidesIBA 01/2022
1	GABA Receptors (GABA Receptor)IBA 01/2022
1	Long Noncoding RNAIBA 12/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2021
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 10/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 04/2015
4	Drug Therapy (Chemotherapy) 01/2022 - 09/2018
3	Intravenous Administration 11/2022 - 04/2016
2	Duration of Therapy 01/2020 - 08/2016
1	Electroacupuncture 01/2022